Search

everythinglearnresearchcommunity

for

Search:↓

Combination antibiotic therapy is more effective but causes more side effects.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Combining medication and minimally invasive techniques can effectively manage Marine-Lenhart syndrome.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Tattoo machine-assisted drug delivery may improve hair growth in androgenetic alopecia.

Mesotherapy is generally safe but can cause adverse reactions due to its varied use and lack of standardization; individualized treatment is needed for these complications.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Injectable PRF therapy may help with hair growth and skin rejuvenation, but more research is needed.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Men are increasingly getting botulinum toxin treatments, requiring higher doses and different techniques than women for a natural look.

Provenge extends prostate cancer survival by about 4 months.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Methotrexate therapy for psoriasis may help regrow hair in some cases of male pattern baldness.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.

Bortezomib chemotherapy can cause temporary skin rashes.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Using PDRN injections and RF treatments improved revision nose surgery results without major side effects.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Combining triamcinolone microinjections with minoxidil improves hair growth in women more than minoxidil alone.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.